Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 174: 116525, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38599057

RESUMO

PURPOSE: We previously showed the beneficial effect of L-Lysine (Lys), a chemical chaperone, on reducing diabetic complications in diabetic rats and type 2 diabetic patients. Herein, we evaluated the effect of Lys co-administration with Vitamin C and Zinc (Lys+VC+Zn), in diabetic rats. METHODS: The streptozotocin (50 mg/Kg) was injected into male adult Wistar rats to induce diabetes. Then, different groups of normal and diabetic rats were treated with Lys and Lys+VC+Zn for five months. So, there were 0.1 % Lys in the drinking water of both groups. The control groups received water alone. During the experiment, the body weight, and various parameters were determined in the blood, serum/plasma, and urine of the rats. RESULTS: The determination of biochemical indexes confirmed diabetes induction and its complications in rats. Treatment with either Lys or Lys+VC+Zn resulted in reduced blood glucose and protein glycation (decreasing AGEs and HbA1c), increased insulin secretion, alleviated insulin resistance and HOMA-IR, improved lipid profile and HDL functionality (LCAT and PON1), enhanced antioxidant status (FRAP and AOPP), improved kidney function (decreased microalbuminuria, serum urea, and creatinine), and increased chaperone capacity (HSP70). Lys+VC+Zn showed better effects on these parameters than Lys alone. CONCLUSIONS: The results of this study indicated that co-administration of Lys, a chemical chaperone, with two antioxidants (VC and Zn) potentiates its antidiabetic effects and prevent diabetic complications in rat model of diabetes.


Assuntos
Antioxidantes , Ácido Ascórbico , Glicemia , Diabetes Mellitus Experimental , Resistência à Insulina , Lipídeos , Lisina , Ratos Wistar , Zinco , Animais , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/sangue , Masculino , Ácido Ascórbico/farmacologia , Ácido Ascórbico/administração & dosagem , Lisina/farmacologia , Lisina/administração & dosagem , Zinco/farmacologia , Antioxidantes/farmacologia , Antioxidantes/administração & dosagem , Ratos , Lipídeos/sangue , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Estreptozocina , Insulina/sangue , Quimioterapia Combinada
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA